CompoAtlas

CARDIO

Natural health product licensed in Canada

Licence holder
Nutraceutech Inc.
NPN or DIN-HM
80106692
Status
Active licence
Licence date
3 December 2020
Revision date
28 June 2021
Form
Capsule
Route of administration
Orale
Application type
Traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Ginkgo biloba

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 50:1

Dry plant equivalent : 4,000 mg

Potency : 6 % Terpéno-lactones

80 mgNot calculated
Origanum vulgare

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 200 mg

50 mgNot calculated
Capsicum annuum

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 20 mg

5 mgNot calculated

Non-medicinal ingredients

Hypromellose, Gomme arabique (acacia), Son de riz, Terre de diatomées (non calcinée)

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule3 Tous les jours

Uses authorised in Canada

Le fragon est utilisé traditionnellement en phytothérapie pour aider à soulager les symptômes tels que l'inconfort et la lourdeur aux jambes reliées aux affections circulatoires mineures. Aide à contribuer au maintien de la circulation périphérique. Source d'antioxydants/Fournis des antioxydants. Utilisé en phytothérapie pour aider à diminuer les taux élevés de lipides sanguins (hyperlipidémie) chez les adultes. Utilisé en phytothérapie pour aider à maintenir la santé cardiovasculaire chez les adultes. Utilisé traditionnellement en phytothérapie pour aider à contribuer au maintien de la circulation périphérique.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80106692

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2021. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line